Among unvaccinated people, the cumulative incidence of #LongCovid declined over the course of the pandemic from a high of 10.4 per 100 adults infected in the pre-delta era to 7.7 per 100 adults infected in the omicron era
Among vaccinated people, the cumulative incidence of #LongCovid declined from 5.3 per 100 adults infected in the delta era to 3.5 per 100 adults infected in the omicron era
Overall, the cumulative incidence of #LongCovid declined from a high of 10.4 per 100 unvaccinated persons infected in the pre-delta era to 3.5 per 100 vaccinated persons infected in the omicron era
Much of the decline (~ 70%) was attributable to vaccination and about 30% was attributable to era effects (i.e. changes in characteristics of the virus and other temporal factors)
We noted a shift in the features of #LongCovid with increased risk of GI and metabolic disorders in omicron – these went up (not down) in omicron compared to prior eras
Millions already have Long Covid, and millions more will continue to be affected. Governments must address the care needs of those with Long Covid, and we must intensify our efforts to understand, prevent, and figure out how to optimally treat Long Covid
The good news: risks of death and post-acute sequelae declined over time in both people who had mild COVID-19 and those with severe COVID-19 that required hospitalization.
Long Covid is likely a disease with many subtypes that may have different risk factors (genetic, environmental, etc.) and distinct biologic mechanisms that may respond differently to treatments.